bluebird bio (BLUE) Tops Q1 EPS by 58c

bluebird bio (NASDAQ: BLUE) reported Q1 EPS of $0.21, $0.58 better than the analyst estimate of ($0.37). Revenue for the quarter came in at $2.4 million versus the consensus estimate of $6.49 million.

For earnings history and earnings-related data on bluebird bio (BLUE) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• Cerebras Systems posts 94% revenue jump, announces OpenAI deal